Search results
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 6 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 3 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
Analysis | Court rejects abortion pill challenge, but what happens next?
Washington Post· 6 days agoWhat do you think is next in the fight over medication abortion? Today’s edition: Senate Republicans...